KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nov (NOV) Capital Expenditures (2016 - 2025)

Nov's Capital Expenditures history spans 17 years, with the latest figure at $101.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 14.41% year-over-year to $101.0 million; the TTM value through Dec 2025 reached $375.0 million, up 6.84%, while the annual FY2025 figure was $375.0 million, 6.84% up from the prior year.
  • Capital Expenditures for Q4 2025 was $101.0 million at Nov, down from $107.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $118.0 million in Q4 2024 and bottomed at $39.0 million in Q3 2021.
  • The 5-year median for Capital Expenditures is $71.5 million (2023), against an average of $71.2 million.
  • The largest annual shift saw Capital Expenditures fell 27.94% in 2021 before it skyrocketed 76.74% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $64.0 million in 2021, then grew by 3.12% to $66.0 million in 2022, then rose by 15.15% to $76.0 million in 2023, then soared by 55.26% to $118.0 million in 2024, then dropped by 14.41% to $101.0 million in 2025.
  • Per Business Quant, the three most recent readings for NOV's Capital Expenditures are $101.0 million (Q4 2025), $107.0 million (Q3 2025), and $83.0 million (Q2 2025).